Sagimet Biosciences Inc

Call
Website

Advertisement

155 Bovet Rd Ste 303
San Mateo, CA 94402
+1 (650) 561-8600
https://sagimet.com

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company located in San Mateo, CA, focused on developing novel fatty acid synthase (FASN) inhibitors. Their lead product candidate, denifanstat, is designed to treat metabolic dysfunction associated with metabolic-associated steatohepatitis (MASH) and is currently undergoing multiple phases of clinical trials.

The company is exploring additional applications for FASN inhibitors, including treatment for acne and select cancer types. Denifanstat has received Breakthrough Therapy designation from the FDA for its potential in treating noncirrhotic MASH with moderate to advanced liver fibrosis.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Infinita Life Science

Infinita Life Science, located in San Mateo, CA, is dedicated to advancing the fields of bio-longevity and health optimization. The company focuses on innovative solutions aimed at helping individuals live younger and longer lives. With a commitment to cutting-edge research and development, Infinita Life Science is poised to make significant contributions to the science of longevity. Their initiatives reflect a forward-thinking approach to enhancing overall well-being and extending healthy lifespans. Generated from the website

Biocodex Inc

Biocodex is a multinational pharmaceutical company that has been committed to healthcare with passion and conviction for over 60 years. With 16 subsidiaries and more than 100 partners, Biocodex has evolved from a French pioneer to an international player in the realm of gut microbiota, specializing in probiotic yeast strains and neurology products. Under the leadership of CEO Nicolas COUDURIER, Biocodex has grown while remaining agile, capitalizing on their values and expanding their expertise in the microbiota field. With 1664 employees worldwide and a revenue of $501 million projected for 2022, Biocodex continues to prioritize healthcare innovation and development.Generated from the website

Forty Seven, Inc

United States›California›San Mateo›Sagimet Biosciences Inc

Partial Data by Infogroup (c) 2025. All rights reserved.

Advertisement